Who owns ALDX?
Institutional ownership of Aldeyra Therapeutics Inc. from Form 13F, Q2 2026
108 institutional managers reported holding Aldeyra Therapeutics Inc. (ALDX) in Form 13F filings for Q2 2026, with 36,733,278 shares worth $78.2M. The largest reported holder was Knoll Capital Management, LLC. Managers that filed both quarters cut a net 473,385 shares (-1.3%). 19 opened new positions and 35 sold out.
- Funds holding
- 108
- Value held
- $78.2M
- New / sold out
- 19 / 35
- Net shares, same filers
- -1.3%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of ALDX
Share of 13F holdings is each fund's shares as a share of the 36,733,278 ALDX shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Marshall Wace, LLP Added+$2.9M
- Qube Research & Technologies Ltd Added+$2.2M
- AQR Capital Management LLC Added+$2.0M
- D. E. Shaw & Co., Inc. Added+$1.1M
- Kingdon Capital Management, L.l.c. Added+$1.1M
- Arrowstreet Capital, Limited Partnership New+$897K
- Jane Street Group, LLC Added+$865K
- Cantor Fitzgerald, L. P. New+$852K
- Gsa Capital Partners LLP Added+$480K
- Acadian Asset Management LLC Added+$437K
Biggest sellers in Q2 2026
- BlackRock, Inc. Trimmed-$5.3M
- State Street Corp Trimmed-$1.9M
- Geode Capital Management, LLC Trimmed-$1.4M
- Millennium Management LLC Trimmed-$1.4M
- Propel Bio Management, LLC Sold out-$1.2M
- Northern Trust Corp Trimmed-$566K
- UBS Group AG Trimmed-$502K
- HRT Financial LP Sold out-$484K
- Susquehanna International Group, LLP Trimmed-$469K
- Bank of America Corp Trimmed-$386K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $17.1M and sold $17.5M; 31 added and 42 trimmed.
Schedule 13D and 13G filings on ALDX
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-06BARCLAYS PLC SCHEDULE 13G filed by Aldeyra Therapeutics Inc.Schedule 13G
- 2026-08-12AQR CAPITAL MANAGEMENT LLC SCHEDULE 13G filed by Aldeyra Therapeutics Inc.Schedule 13G
Questions about ALDX ownership
- Who owns ALDX stock?
- 108 institutional investment managers reported ALDX positions in their Form 13F filings for Q2 2026, holding 36,733,278 shares worth $78.2M in total. Knoll Capital Management, LLC reported the largest position.
- Are funds buying or selling ALDX?
- In Q2 2026, 19 managers opened new ALDX positions, 31 added, 42 trimmed and 35 sold out. Managers that filed in both quarters sold a net 473,385 shares.
- How current is this ALDX institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to ALDX by CUSIP. Options are left out. ALDX news and filings · ALDX insider trades · Top funds